Edition:
United Kingdom

Abcam PLC (ABCA.L)

ABCA.L on London Stock Exchange

1,353.00GBp
4:51pm BST
Change (% chg)

37.00 (+2.81%)
Prev Close
1,316.00
Open
1,309.00
Day's High
1,362.00
Day's Low
1,309.00
Volume
458,722
Avg. Vol
437,979
52-wk High
1,643.80
52-wk Low
946.77

Latest Key Developments (Source: Significant Developments)

Abcam Says FY Pretax Profit Rose 33.1 Pct To 69.1 Mln Stg
Monday, 10 Sep 2018 

Sept 10 (Reuters) - Abcam PLC ::FY PRETAX PROFIT ROSE 33.1 PERCENT TO 69.1 MILLION STG.FY REVENUE ROSE 7.4 PERCENT TO 233.2 MILLION STG.LONG-TERM MARKET OUTLOOK REMAINS POSITIVE; GOOD MOMENTUM ACROSS BUSINESS.PROPOSED FINAL DIVIDEND OF 8.58P (2016/17: 7.36P) FOR FY.AMBITION TO MAINTAIN REVENUE GROWTH AT LOW DOUBLE-DIGIT RATES OVER MEDIUM-TERM.ANTICIPATE 2018/19 ADJUSTED EBITDA MARGIN OF ABOUT 36 PCT AS A RESULT OF INCREASED INVESTMENT IN STRATEGIC INITIATIVES.EXPECT TOTAL CONSTANT CURRENCY REVENUE GROWTH FOR 2018/19 OF ABOUT 11 PCT.  Full Article

Abcam Expects FY Rev At Constant Currency To Rise 10.7 Pct
Thursday, 12 Jul 2018 

July 12 (Reuters) - Abcam PLC ::EXPECT TO REPORT REVENUE GROWTH FOR YEAR OF 10.7% ON A CONSTANT CURRENCY BASIS AND 7.4% ON A REPORTED BASIS.FY GROUP REPORTED GROSS MARGIN IS EXPECTED TO BE BROADLY IN LINE WITH LAST YEAR (FY2017: 70.1%).EXPECTS TO DELIVER AN ADJUSTED EBITDA MARGIN IN LINE WITH BOARD'S EXPECTATIONS FOR FY.  Full Article

Abcam Says Entered Into License Agreement With Roche​
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Abcam Plc ::‍HAS ENTERED INTO A DEFINITIVE LICENSE AGREEMENT WITH ROCHE​.‍WILL OBTAIN EXCLUSIVE RIGHTS TO PRODUCT PORTFOLIO OF SPRING BIOSCIENCE CORPORATION IN RESEARCH USE ONLY (RUO) FIELD OF USE.ROCHE TO RETAIN ANTIBODY DEVELOPMENT CAPABILITIES, RIGHTS TO SPRING PORTFOLIO FOR INTERNAL RESEARCH, COMPANION DIAGNOSTIC, IVD USES​​.ALL PRODUCTS TO BE SOLD UNDER ABCAM BRAND, INCLUSIVE OF SP BRANDING, ARE EXPECTED TO BE AVAILABLE THROUGH ABCAM.COM FROM 21 FEBRUARY 2018​.GRANTED EXCLUSIVE RUO RIGHTS FOR FUTURE PRODUCTS DEVELOPED BY SPRING THAT ROCHE REQUESTS TO BE COMMERCIALISED IN RUO FIELD OF USE FOR INITIAL PERIOD OF 10 YEARS.‍FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED​.  Full Article

Abcam Says Signed Exclusive License Agreement with Roche
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Abcam Plc ::‍HAS ENTERED INTO A DEFINITIVE LICENSE AGREEMENT WITH ROCHE​.‍WILL OBTAIN EXCLUSIVE RIGHTS TO PRODUCT PORTFOLIO OF SPRING BIOSCIENCE CORPORATION ("SPRING") IN RESEARCH USE ONLY (RUO) FIELD OF USE​.‍WILL RETAIN ANTIBODY DEVELOPMENT CAPABILITIES AND RIGHTS PERTAINING TO SPRING PORTFOLIO FOR INTERNAL RESEARCH, COMPANION DIAGNOSTIC AND IVD USES​.‍ALL PRODUCTS WILL BE SOLD UNDER ABCAM BRAND, INCLUSIVE OF SP BRANDING, AND ARE EXPECTED TO BE AVAILABLE THROUGH ABCAM.COM FROM 21 FEBRUARY 2018​.‍HAS ALSO BEEN GRANTED EXCLUSIVE RUO RIGHTS FOR ALL FUTURE PRODUCTS DEVELOPED BY SPRING THAT ROCHE REQUESTS TO BE COMMERCIALISED IN RUO FIELD OF USE FOR AN INITIAL PERIOD OF 10 YEARS.‍FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED​.  Full Article

Abcam Says On Track TO DELIVER 10% FY CONSTANT CURRENCY REVENUE GROWTH
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Abcam Plc ::ABCAM PLC - WE EXPECT TO REPORT REVENUE GROWTH FOR FIRST HALF OF APPROXIMATELY 11 PCT.ABCAM PLC - REMAIN ON TRACK TO DELIVER AGAINST OUR CONSTANT CURRENCY REVENUE GROWTH TARGET OF AROUND 10% FOR FULL YEAR.ABCAM PLC - CATALOGUE REVENUE GREW BY OVER 11% IN FIRST HALF OF YEAR.  Full Article

Abcam's Murray Hennessy to step down from non-executive chairman position
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Abcam Plc :‍CHAIRMAN, MURRAY HENNESSY, HAS INFORMED BOARD THAT HE HAS ACCEPTED A CEO ROLE​.‍HENNESSY WILL THEREFORE RELINQUISH HIS NON-EXECUTIVE CHAIRMAN POSITION AND STEP DOWN FROM BOARD FOLLOWING AGM IN NOVEMBER 2017​.ABCAM - ‍LOUISE PATTEN, CURRENTLY SERVING AS SENIOR INDEPENDENT DIRECTOR OF ABCAM, WILL TAKE OVER AS INTERIM NON-EXECUTIVE CHAIRMAN AT AGM CONCLUSION​.  Full Article

Abcam posts FY pretax profit 51.9 mln stg
Monday, 11 Sep 2017 

Sept 11 (Reuters) - Abcam Plc ::FY PRETAX PROFIT 51.9 MILLION STG.FY REVENUE ROSE 26.5 PERCENT TO 217.1 MILLION STG.FINAL DIVIDEND 7.355 PENCEPER SHARE.TOTAL DIVIDEND 10.18 PENCEPER SHARE.  Full Article

Abcam says current year has started well
Wednesday, 2 Nov 2016 

Abcam Plc : Current year has started well and we are making good progress against our strategic priorities and growth objectives - chairman .Remain confident that we can continue to build significant value for all of our stakeholders - chairman.  Full Article

UPDATE 1-UK Stocks-Factors to watch on Sept 10

Sept 10 - Britain's FTSE 100 index is seen opening up 19 points at 7,297 points on Monday, according to financial bookmakers, with futures up 0.16 percent ahead of the cash market open.